AMRN
Amarin Corporation PLC
NASDAQ: AMRN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$14.29
+2.36% today
Updated 2026-04-29
Market cap
$300.12M
P/E ratio
—
P/S ratio
1.41x
EPS (TTM)
$-1.80
Dividend yield
—
52W range
$9 – $21
Volume
0.1M
WallStSmart proprietary scores
39
out of 100
Grade: D
Sell
Investment rating
2.0
Growth
F7.8
Quality
B+2.0
Profitability
F7.7
Valuation
B+4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$12.00
-16.03%
12-Month target
—
—
Intrinsic (DCF)
$142.07
Margin of safety
+89.36%
0 Strong Buy0 Buy1 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $6.39M — positive
+ 89.36% below intrinsic value
+ Debt/equity 0.01x — low leverage
Risks
- Thin margins at -18.20%
- Revenue declining -21.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $369.19M | $306.91M | $228.61M | $182.75M | $213.65M |
| Net income | $-105.80M | $-59.11M | $-82.18M | $-38.80M | $-10.51M |
| EPS | — | — | — | — | $-1.80 |
| Free cash flow | $-179.98M | $6.88M | $-31.02M | $6.74M | $6.39M |
| Profit margin | -28.66% | -19.26% | -35.95% | -21.23% | -18.20% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-02-01 | PROVOOST, JONATHAN | Buy | 36,060 | — |
| 2026-02-01 | PROVOOST, JONATHAN | Buy | 8,013 | — |
| 2026-02-01 | KETCHUM, STEVEN B | Buy | 36,060 | — |
Peer comparison
Smart narrative
Amarin Corporation PLC trades at $14.29. Our Smart Value Score of 39/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $213.65M. with profit margins at -18.20%. Our DCF model estimates intrinsic value at $142.07.
Frequently asked questions
What is Amarin Corporation PLC's stock price?
Amarin Corporation PLC (AMRN) trades at $14.29.
Is Amarin Corporation PLC overvalued?
Smart Value Score 39/100 (Grade D, Sell). DCF value $142.07.
What is the price target of Amarin Corporation PLC (AMRN)?
The analyst target price is $12.00, representing -16.0% downside from the current price of $14.29.
What is the intrinsic value of Amarin Corporation PLC (AMRN)?
Based on our DCF model, intrinsic value is $142.07, a +89.4% margin of safety versus $14.29.
What is Amarin Corporation PLC's revenue?
TTM revenue is $213.65M.
Piotroski F-Score?
4/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.41x
ROE-8.21%
Beta0.82
50D MA$14.82
200D MA$15.55
Shares out0.02B
Float0.37B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—